Myasthenic crisis in the setting of Coronavirus Disease 2019 (COVID-19)

• A patient with Myasthenia Gravis (MG) on immunosuppressive therapy with underlying respiratory compromise may be more susceptible to infection with COVID-19 or severe manifestations of the virus. • It is theorized that patients with MG may be more vulnerable to bacterial and viral infections, due...

Descripción completa

Detalles Bibliográficos
Autores principales: Salik, Irim, Rodhouse, Heather Brosnan, Barst, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368911/
https://www.ncbi.nlm.nih.gov/pubmed/32707518
http://dx.doi.org/10.1016/j.jclinane.2020.110001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368911/
https://www.ncbi.nlm.nih.gov/pubmed/32707518
http://dx.doi.org/10.1016/j.jclinane.2020.110001

Ejemplares similares